Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online ...

Popular GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight, but what should patients know about ...

The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of GLP-1 weight-loss ...

Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...

The Biden administration has called for Medicare and Medicaid to expand coverage of weight-loss drugs for people struggling ...

People taking Ozempic and Wegovy, which contain the drug semaglutide, may be at an increased risk of developing a ...

The findings, published Friday in JAMA Health Forum, suggest that blockbuster medications such as Novo Nordisk A/S’s Ozempic and Wegovy and Eli Lilly & Co.’s Mounjaro and Zepbound may actually be ...

Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.

Ironically, Ozempic and Wegovy, as with many of Novo Nordisk’s other products ... They’re concerned about falling behind the ...

It is crucial for patients using Wegovy to commit to a long-term treatment plan, as stopping the medication can lead to ...

Over half of American adults are eligible for semaglutide, but insurance and other barriers make it hard for people to access ...